HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Intelligence

Set Alert for Market Intelligence

Immune Health Vitamins And Minerals Drove German Supplement Market Growth In 2021

Double-digit increases in sales of omega 3 supplements, vitamin A and D combinations and single product B vitamins helped Germany's dietary supplements market grow by 2.1% to €2.7bn in 2021, according to IQVIA Commercial. 

Germany Dietary Supplements

L’Oréal Strongest In Beauty ‘Brand Impact,’ While Lauder Gaining Value Fastest

L’Oréal is the most valuable beauty brand globally, according to consultancy Brand Finance’s annual report from its methodology ranking 50 most valuable brands in cosmetics, skin care, hair care and personal care. Estee Lauder ranked second.

Research & Development Market Intelligence

UK Marketing Round-Up: Launches From Healthspan, Lanes, A Vogel And Dermal

Healthspan adds New Zealand blackcurrant supplement to Elite range; Lanes Health brings Nordic iron supplement to UK, A Vogel offers British consumers an eco-friendly eye dropper version of Pollinosan; and Dermal Laboratories launches Doublebase Once.  

United Kingdom Health

'Tectonic' Shifts In Germany’s OTC Market Require Smart Sales Strategies

Data from Sempora Consulting shows Germany's OTC market is still struggling to return to pre-pandemic growth levels in the first quarter of 2022. Digging deeper into recent trends like e-commerce and inflationary pricing, the firm suggests a number of points for consumer healthcare companies to consider in formulating their sales strategies for the rest of the year.

Germany Health

Over The Counter 9 May 2022: The Landscape Of Naloxone Access With HRT’s Michael Hufford

In this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility in the US of naloxone, a life-saving opioid overdose antidote. Hufford unpacks the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies currently producing prescription naloxone to make the switch to OTC status, and why many of them have chosen not to. While the financial incentive may not be there, the public health need is dire, and Hufford explains the importance of harm reduction groups and non-profit pharmaceutical companies for getting naloxone into the hands of those who need it the most.

US States Health

Health And Wellness Weekly Trademark Review 3 May

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs
See All